Importantly, recent research has confirmed that SPOP functions as a tumor suppressor in hepatoblastoma (HB) development via the PI3K/Akt pathway, with its anti-cancer activity impaired by the S119N mutation 272. Here, AKT1 is linked to neoplasm.